Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1181

MOR07692-hIgG1

Home » MOR07692-hIgG1

Background of MOR07692-hIgG1

MST1R (Macrophage-stimulating protein receptor), is a receptor tyrosine kinase belonging to the tumor necrosis factor receptor family. Overactivation of MST1R in cancer is associated with tumorigenesis, progression, and metastasis. Studies have shown that MST1R is highly expressed in various tumors, including lung cancer, breast cancer, gastric cancer, colorectal cancer, and others. Therefore, MST1R has emerged as a potential target for cancer therapy. Researchers are actively developing MST1R inhibitors to suppress its activity, thereby interfering with processes such as tumor cell proliferation, migration, and invasion.

Specifications

Catalog Number:
KB-1181
Antibody Name:
MOR07692-hIgG1
Isotype:
Human IgG1,kappa
FC Muations:
Wild Type
Target:
MST1R
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
FACS
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Catenacci D V T , Cervantes G , Yala S ,et al.RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma[J].Cancer Biology & Therapy, 2011, 12(1):9-46.
  2. Catenacci D V T , Henderson L , Cervantes G ,et al.Abstract LB-124: RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma[J].Cancer Research, 2011, 71(8 Supplement):9-46.